Preferred Clinical Research Team Assists In New COVID Vaccine Development
Doctors at Preferred Primary Care Physicians in Pleasant Hills are assisting in the clinical trial of the Novavax vaccine. They explained how the Novavax vaccine is different from the other vaccines.
“The safety profile for the Novavax vaccine is very promising. There are no reported incidents of heart inflammation or blood clotting,” said Alan Abraham, the director of clinical research at Preferred Primary Care Physicians.
“The side effects are far less severe and less frequent. We are also seeing injection site pain and minor fatigue, but nothing like the flu-like symptoms of some of the other reported vaccines.”
This entry was posted in Clinical Research, COVID-19. Bookmark the permalink.